Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if cyclophosphamide given after busulfan
and fludarabine can help to prevent graft versus host disease (GVHD - a condition in which
transplanted tissue attacks the body into which it is transplanted) in patients receiving a
stem cell transplant. The safety of this drug combination will also be studied.